July 15 (Reuters) – British bootmaker Dr Martens stuck to its fiscal 2027 outlook on Wednesday, citing encouraging wholesale demand in its largest market, the United States.
Here are some more details:
• Trading has been in line with expectations since the start of its financial year in April, the company said.
• Dr Martens said Japan and South Korea were performing well and the European markets were also in line with expectations despite a challenging consumer backdrop.
• In May, Dr Martens reported a revenue decline from the Europe, Middle East and Africa region as the economic fallout from the Iran war weighed on consumer spending.
• The company is expected to report adjusted pretax profit of £68 million ($91.21 million) for fiscal 2027, according to a company-compiled consensus.
• Shares of the company rose as much as 3.8% to 75.5 pence in early trading before surrendering gains to trade flat by 0731 GMT.
($1 = £0.7455)
(Reporting by Neeshita Beura in Bengaluru; Editing by Subhranshu Sahu)
